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about limited growth potential of the circumferential
anastomosis. In 1966, Waldhausen and Nahrwold3
reported subclavian flap angioplasty (SFA), which
became the method of choice in many centers. With
successful repair of transposition of the great arteries
and lessening fear of a circumferential anastomosis,
together with concern about arch hypoplasia, the end-
to-end anastomosis repair and modified or extended
end-to-end anastomosis has regained popularity. It
remains unclear, however, whether end-to-end anasto-
mosis or SFA is the technique of choice. No random-
ized trials have been published, and the follow-up of
some of the newer modifications of end-to-end anasto-
mosis repair is short. We report our experience with a
standardized technique for subclavian flap repair over
a 24-year period. This study is unique because, at fol-
low-up, recoarctation was assessed in all patients by
means of transthoracic echocardiography with Doppler
studies.4
T he surgical management of neonatal and infantilecoarctation of the aorta continues to evolve. In 1945,
Gross and Hufnagel1 at Children’s Hospital in Boston
reported resection and end-to-end anastomosis. In a
report of 500 patients who underwent end-to-end anas-
tomosis repair, Schuster and Gross2 expressed concern
Objectives: We sought to assess the early and long-term results of subclavian
flap angioplasty in neonates and infants, with particular attention to growth
of the hypoplastic arch.
Methods: A retrospective analysis of 185 consecutive patients who under-
went subclavian flap angioplasty between 1974 and 1998 was carried out.
The patients included 125 neonates and 60 infants, with a median age of 18
days. Sixty-six (36%) patients had an additional ventricular septal defect, 41
(22%) patients had aortic arch hypoplasia diagnosed preoperatively, 141
(76%) had an associated patent ductus arteriosus, and 41 (22%) had addi-
tional complex heart disease. Follow-up was with transthoracic Doppler
echocardiography in all patients.
Results: The early mortality was 3%. Recoarctation, defined as a Doppler
gradient of 25 mm Hg or more, occurred in 11 (6%) patients at a median fol-
low-up of 6.2 years (6.2 ± 4.6 years). This included 4 of the 41 patients in
whom arch hypoplasia was diagnosed preoperatively. There were no com-
plications with the left arm. By multivariate analysis, risk factors for death
were determined to be residual arch hypoplasia and low birth weight. The
only risk factor for recoarctation was persistent arch hypoplasia after surgi-
cal treatment. However, angiographic imaging of the aorta showed that
recoarctation was not due to a hypoplastic transverse arch, and it was prob-
ably at the site of ductal tissue. Survival at 5 and 10 years was 98% and 96%,
respectively. Freedom from reoperation for recoarctation at 2 years was 95%,
and at 5, 10, and 15 years, it was 92%.
Conclusions: Subclavian flap repair remains an effective technique for repair
of aortic coarctation with excellent results and low mortality. In the majori-
ty of patients, arch hypoplasia regresses after this procedure. (J Thorac
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Methods
Patient population. Between January 1974 and December
1998, 185 patients underwent SFA for coarctation of the aorta
at The Royal Brompton Hospital under the care of one surgi-
cal team. The patients were referred to the duty surgical ser-
vice, and therefore there was no potential for selection bias.
There were 125 (68%) neonates (≤30 days) and 60 (32%)
infants. Sixty-four (35%) were girls, and 121 (65%) were
boys. Fifty-two (28%) patients underwent an operation
between 1974 and 1985, and 133 (72%) patients underwent
an operation between 1986 and 1998. The median age at the
time of the operation was 18 days. The median age for the
neonates was 8 days. The median weight for all patients was
3.6 kg (range, 1.2-10.0 kg), and the median weight for
neonates was 3.3 kg (range, 1.2-5.6 kg). Diagnosis of coarc-
tation of the aorta in all patients was the indication for surgi-
cal treatment. This diagnosis was made in all patients by
transthoracic echocardiography. Eighteen (10%) patients also
underwent cardiac catheterization. Catheterization was per-
formed in the earlier part of the study and in patients with
associated cardiac anomalies. Sixty-three (34%) patients
were receiving alprostadil (prostaglandin) infusions before
the operation. Twenty-two (12%) patients were in heart fail-
ure and required assisted ventilation before the operation.
None of the patients had evidence of a cerebral hemorrhage.
Four (2%) patients had sepsis confirmed by positive blood
cultures.
Associated cardiac anomalies. Associated cardiac anom-
alies are shown in Table I. Ventricular septal defects (VSDs)
were classified according to their size and number; small,
moderate, or large size (nonlimiting); and single or multiple
status.
Arch hypoplasia. The aortic arch was assessed at 3 differ-
ent times: (1) in the preoperative period by transthoracic
echocardiography, (2) by the surgeon at the time of the oper-
ation, and (3) in the follow-up period by transthoracic
echocardiography, cardiac catheterization, or magnetic reso-
nance imaging. We have defined hypoplasia of the distal arch
according to the criteria of Moulaert and colleagues5; that is,
the diameter of the aorta between the common carotid and
left subclavian arteries was less than 50% of the diameter of
the ascending aorta. Arch hypoplasia was present in 41 (22%)
patients. This was diagnosed in all by preoperative transtho-
racic echocardiography and subsequently confirmed at the
time of the operation. Patients with an interrupted aortic arch
were excluded from the study.
Surgical technique. Before the operation, pressure was
measured in the right radial artery and the right or left femoral
artery. All patients underwent repair through a left-sided pos-
terolateral thoracotomy. The aortic arch, subclavian artery,
aortic isthmus, and descending thoracic aorta were exposed
and dissected free. The ductus was divided, clipped, or both,
with a clip (Ligaclip; Ethicon Endo-Surgery, Cincinnati,
Ohio). The left subclavian artery was ligated in its very distal
segment before its first branch. An incision was made just
over the descending thoracic aorta distal to the coarctation of
the aorta area. This is extended across the coarctation area
into the subclavian artery. We extended the aortotomy at least
5 mm distal to the coarctation of the aorta, so that the distal
end of the aortotomy (ie, the site of the distal anastomosis)
does not lie opposite the ductal area. Before anastomosing the
flap, we excised any excessive ductal tissue that protruded
into the lumen of the aorta. All operations were performed by
this technique. A single surgeon (C.L.) operated on 128
(69%) patients and his trainees operated on the remaining 57
(31%) patients.
Follow-up in the early postoperative period. Seventy-
four (40%) patients underwent transthoracic echocardiogra-
phy before discharge from the hospital. 
Follow-up after hospital discharge. All patients were
seen by the referring cardiologist at The Royal Brompton
Hospital or by one of the cardiologists in an outreach clinic.
Follow-up was complete and up to date in all patients.
Recoarctation. Recoarctation was assessed by means of
clinical examination, transthoracic echocardiography, or
both. Recoarctation was defined when the arm-leg blood
pressure difference was greater than 20 mm Hg or if a gradi-
ent of more than 25 mm Hg was noted by means of transtho-
racic echocardiography, the presence of a diastolic tail to the
continuous wave Doppler signal in the descending aorta, or
both.4
Statistical analysis. The outcome variables were survival
and recoarctation. Univariate analyses for categoric predic-
tors were evaluated by the Fisher exact test. Actuarial esti-
mates for survival and freedom from recoarctation with 95%
Greenwood confidence intervals (CIs) were determined by
the Kaplan-Meier product-limit method. Survival curves
were compared by the log-rank test.6 The Cox proportional
hazards regression model was used to establish the variables
that were independently associated with each outcome, with
risk measured by the hazard ratio using 95% confidence lim-
its.7 For survival analysis, recoarctation was tested as a time-
dependent covariate in the Cox model. Other covariates
included age as both a continuous and categoric (neonates vs
Table I. Associated cardiac anomalies
Anomaly No. (%)
VSD 66 (36)
Small 41 (62)
Moderate 7 (11)
Large 15 (23)
Multiple 3 (5)
Bicuspid aortic valve 33 (18)
Atrial septal defect 22 (12)
Mitral valve anomaly 14 (8)
Subaortic stenosis 6 (3)
Aortic valve stenosis 4 (2)
Discordant ventriculoarterial connection 6 (3)
Absent right atrioventricular connection 2 (1)
Double-inlet left ventricle 4 (2)
Double-outlet right ventricle 4 (2)
Taussig-Bing anomaly 1 (1)
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infants) variable, sex, year of operation, and weight as con-
tinuous variables, and surgeon, presence or absence of sepsis,
associated cardiac anomalies, arch hypoplasia, and
alprostadil (prostaglandin) infusion as categoric variables. A
forward stepwise selection procedure was used to construct
the final multivariate models, and a significance level of .05
was required for a variable to be retained as a risk factor in
the model. The SAS software package version 6.12 was used
for all statistical analysis (SAS Institute, Cary, NC).
Results
Early mortality. There were 6 (3%) deaths within 30
days of the operation. Survival at 5 years was 98% ± 2%,
and survival at 10 and 15 years was 96% ± 2% (Fig 1).
Results obtained by the Cox multivariate regression
identified 2 independent risk factors associated with
death: persistent arch hypoplasia after the operation (P <
.0001) and year of operation (P = .02). Because younger
age as a continuous variable was found to be a risk fac-
tor, this variable was categorized into 2 subgroups to
compare neonates and infants. None of the other vari-
ables were found to be significant in the multivariate
analysis (P > .1 in each case). Regression coefficients,
SEs, hazard ratios, and 95% CIs are shown in Table II.
Four patients died on the first postoperative day. One
died of persistent acidosis and low cardiac output. The
second had an associated VSD and died of low cardiac
output on the operating table. The third patient died of
sudden bradycardia unresponsive to pharmacologic
means a few hours after the operation, and the final
patient had severe metabolic acidosis. Two further
patients were unable to be weaned from the ventilator,
and intractable respiratory failure developed.
Follow-up. At 5-year follow-up, of 179 patients, 146
(82%) had undergone transthoracic echocardiography
where systolic gradient and diastolic tail were assessed.
A further 33 patients who had not had a transthoracic
Fig 1. Kaplan-Meier actuarial survival for all 185 patients. Error bars indicate 95% CIs based on the Greenwood
formula. Estimated cumulative survival at 10 years was 96% (95% CI, 93%-99%). The number of patients alive
and at risk in the follow-up period are provided in parentheses at selected time points.
Table II. Multivariate risk factors for death and recoarctation on the basis of the Cox model
Risk factor Coefficient SE Hazard ratio 95% CI P value
Death
Arch hypoplasia 4.50 1.10 89.9 12.7-631 <.0001
Year of operation –0.15 0.06 0.9 0.8-0.95 .02
Recoarctation
Arch hypoplasia 2.75 1.08 15.5 2.2-110 .01
Age (y) –0.05 0.02 0.9 0.85-0.94 <.001
Year of operation –0.10 0.04 0.9 0.83-0.96 .03
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echocardiogram in the follow-up period were contacted
and called back for an echocardiogram. Fifty-one
(28%) patients underwent cardiac catheterization; 32 of
these were performed in the first 5 years of the study.
Seven (4%) patients underwent magnetic resonance
imaging.
Recoarctation. Eleven (6%) patients had recoarcta-
tion after a median time of 6.2 years (6.2 ± 4.6 years).
The freedom from recoarctation at 2 years was 95%
(95% CI, 92%-98%), and at 5, 10, and 15 years, it was
92% (95% CI, 88%-96%; Fig 2). This is also shown in
Fig 3, where neonates and infants are compared.
Results obtained by the Cox multivariable regression
established 3 independent risk factors associated with
recoarctation: persistent arch hypoplasia after the oper-
ation (P = .01), year of operation (P = .03), and age as
a continuous variable (P < .001). None of the other
variables were significantly associated with recoarcta-
tion in the Cox multivariate analysis (P > .1 in each
case). Regression coefficients, SEs, hazard ratios, and
95% CIs are shown in Table II. As shown in Table II,
the more recent operations, reflected by a negative
coefficient and a hazard ratio of less than 1, are associ-
ated with lower risk of survival and recoarctation. The
details of the 11 patients who had recoarctation and
required reintervention are shown in Table III. Three
patients had reoperation. Two of these had arch
hypoplasia diagnosed preoperatively, and this was per-
sistent at follow-up. However, the recoarctation was at
the distal site of the anastomosis. Repair was per-
formed by resection and end-to-end anastomosis. Eight
underwent balloon dilatation. Follow-up was complete
in all these patients, with a median time of 6.5 years
(range, 1-11 years). In all patients after reintervention,
the postintervention gradient was less than 20 mm Hg.
This was demonstrated in all patients by transthoracic
Fig 2. Kaplan-Meier actuarial freedom from recoarctation for all 185 patients. Error bars indicate 95% CIs based
on the Greenwood formula. Estimated freedom from recoarctation at 10 years was 96% (95% CI, 88%-96%). The
numbers of patients remaining free from recoarctation and at risk in the follow-up period are provided in paren-
theses at selected time points.
Table III. Characteristics of patients with recoarctation
of the aorta
Preintervention 
Patient gradient, mm Hg Reintervention 
No. (interval from first operation) (F/U)
1 28 (4 y) Balloon (10 y)
2 52 (2.5 y) Balloon (10 y)
3 40 (3 d) Operation (12 y)
4 45 (3 mo)* Balloon (4 y)
5 70 (1.5 y) Balloon (6.5 y)
6 42 (2 y)* Balloon (11 y)
7 44 (3 mo) Balloon (3.5 y)
8 50 (11 mo) Operation (5 y)
9 30 (3.5 y) Balloon (5 y)
10 60 (5 mo) Operation (3 y)
11 40 (1.5 y) Balloon (1 y)
The preintervention gradient is obtained by Doppler echocardiography. F/U,
Follow-up.
*Patients with two episodes of recoarctation. The gradients are before the
second reintervention.
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echocardiography and confirmed in 6 patients by
means of aortography.
Patients with arch hypoplasia. Of the 41 (22%)
patients with a preoperative diagnosis of arch hypopla-
sia, 4 (10%) had persistent arch hypoplasia diagnosed at
1.5, 2, 3, and 8 years after the surgical treatment. In all
4 patients, cardiac catheterization was performed, and 2
patients also underwent magnetic resonance imaging.
Patients with VSDs. Of the 66 (36%) patients with
VSDs, 17 underwent pulmonary artery banding at the
time of coarctation repair. Fifteen had a large VSD, 1
had multiple VSDs, and 1 had a moderate-sized VSD.
The remainder were stable and did not require con-
comitant pulmonary artery banding. The small-sized
VSDs in 38 of the 41 patients had closed spontaneous-
ly at a median follow-up of 4.3 years. All other patients
underwent surgical closure.
Surgical complications. The left arm function was
not assessed formally but rather on the basis of symp-
toms and general appearance. None of the patients had
any neurologic or ischemic complications involving the
left arm, either at early or late follow-up. None had
aneurysm formation. One patient was hypertensive at
follow-up, requiring medication.
Discussion
The optimal surgical management of coarctation
remains controversial, despite more than 50 years of
experience with treatment of this condition. The con-
troversies concern several issues: (1) method of repair,
(2) growth of the hypoplastic arch, (3) treatment of
associated anomalies, and (4) incidence and assesse-
ment of recoarctation. All areas of contention are due in
part to the lack of prospective randomized studies and
in part to a lack of uniformity in defining recurrence of
coarctation of the aorta and arch hypoplasia.
The aim of this study was not to compare different
surgical methods for the repair of coarctation of the
aorta. Our policy has been to perform SFA in all
neonates and small infants. In addition to reporting out-
comes, the particular concern of the study was to
determine whether SFA would facilitate growth of the
aortic arch without the need for surgical augmentation.
Recent reports have shown a trend toward forms of
end-to-end anastomosis for repair of coarctation of the
aorta and highlighted the potential disadvantages of
SFA.8 These include leaving the ductal tissue, which
may contribute to subsequent recoarctation, the inabil-
ity to relieve coexistent arch hypoplasia, the inherent
disadvantage of having to sacrifice the left subclavian
artery, and the possibility of an increased risk of late
aneurysm formation in the abnormal tissue of the pos-
terior aortic wall. However, these potential disadvan-
tages are not borne out in the literature or in our data.
Ziemer and colleagues9 reported on 100 patients, 70%
of whom underwent SFA and 24% of whom underwent
Fig 3. Kaplan-Meier estimated freedom from recoarctation according to age categorized into infants and neonates
(P = .01; log-rank test, 6.17). Error bars indicate 95% CIs based on the Greenwood formula. The numbers of
patients remaining free from recoarctation and at risk in the follow-up period are provided in parentheses at
selected time points for infants (top row) and neonates (bottom row).
long-term survival when compared with those with-
out a VSD.
We believe that SFA still provides an excellent
method of repair for neonatal and infantile coarctation
of the aorta. When properly performed in patients with
simple additional defects, this technique gives rise to a
low incidence of recoarctation, and adequate arch
growth occurs without the need for augmentation.
We thank Ms Li Chung and Ms Andrea Mather for their
invaluable assistance in collecting the data and organizing
follow-up echocardiography.
R E F E R E N C E S
1. Gross RE, Hufnagel CA. Coarctation of the aorta: experimental
studies regarding its surgical correction. N Engl J Med
1945;233:287-93.
2. Schuster SR, Gross RE. Surgery for coarctation of the aorta: a
review of 500 cases. J Thorac Cardiovasc Surg 1962;43:54-70.
3. Waldhausen JA, Nahrwold DL. Repair of coarctation of the aorta
with a subclavian flap. J Thorac Cardiovasc Surg 1966;51:532-3.
4. Carvalho J, Redington AN, Shinebourne EA, Rigby ML, Gibson
D. Continuous wave Doppler and coarctation of aorta: gradients
and flow patterns in the assessment of severity. Br Heart J
1990;76:133-7.
5. Moulaert AJ, Bruins CC, Oppenheimer-Dekker A. Anomalies of
the aortic arch and ventricular septal defect. Circulation
1976;95:265-74.
6. Kaplan EL, Meier P. Nonparametric estimation from incomplete
observations. J Am Stat Assoc 1058;53:457-81.
7. Cox DR. Regression models and life-tables. J R Stat Soc Series
B 1972;34:187-202.
8. Jonas RA. Do we need to resect ductal tissue? Ann Thorac Surg
1991;52:604-7.
9. Ziemer G, Jonas RA, Perry SB, Freed MD, Castaneda AR.
Surgery for coarctation of the aorta in the neonate. Circulation
1986;74(Suppl):I-25-31.
10. Knott-Craig CJ, Elkins RC, Ward KE, Overholt ED, Razoook JD,
McCue CA, et al. Neonatal coarctation repair: influence of tech-
nique on late results. Circulation 1993;88(5 Pt 2):II-198-204.
11. Siewers RD, Ettedgui J, Pahl E, Tallman T, del Nido PJ.
Coarctation and hypoplasia of the aortic arch: Will the arch
grow? Ann Thorac Surg 1991;52:608-14.
12. Conte S, Lacour-Gayet F, Serraf A, Sousa-Uva M, Bruniaux J,
Touchot A, et al. Surgical management of neonatal coarctation. J
Thorac Cardiovasc Surg 1995;109:663-75.
13. Quaegebeur JM, Jonas RA, Weinberg AD, Blackstone EH,
Kirklin JW. Outcomes in seriously ill neonates with coarctation
of the aorta: a multiinstitutional study. J Thorac Cardiovasc Surg
1994;108:841-54.
The Journal of Thoracic and
Cardiovascular Surgery
Volume 120, Number 2
Jahangiri et al 229
end-to-end anastomosis repair. Freedom from reinter-
vention for recoarctation after 5 years was not signifi-
cantly different between the 2 groups. Similarly, others
have shown no difference in recoarctation rates
between SFA and end-to-end anastomosis.10,11 We
report a recoarctation rate of 6%. This is lower than
other figures in the literature, which report rates from
9.8%11 to 24%.9
It is unlikely that we have underestimated our inci-
dence of recoarctation because 146 (81%) patients
underwent transthoracic echocardiography, with
Doppler studies performed at the latest follow-up.
Borderline cases were additionally investigated by
angiography or magnetic resonance imaging. This dif-
fers from most other reports in which recoarctation was
assessed by arm-leg blood pressure differences alone,
and therefore in those series its incidence may have
been underestimated.
One of the potential advantages of extended end-to-
end anastomosis repair is the ability to deal with arch
hypoplasia at the time of presentation.12 This is clearly
not the case with SFA, but adequate growth (presum-
ably resulting from improved arch flow characteristics)
was achieved in the vast majority of our patients.
Nonetheless, arch hypoplasia persisted in 2% of the
patients and was indeed identified as a risk factor for
subsequent recoarctation, although no patients required
arch augmentation. In these patients angiographic
imaging of the aorta showed that recoarctation was not
due to a hypoplastic transverse arch, and it was proba-
bly at the site of ductal tissue. On this basis, we concur
with Sewers and colleagues11 that in the vast majority
of patients, there is no need for extensive resection and
aggressive enlargement of the hypoplastic arch.
As for the treatment of patients with an associated
large or moderately large VSD, we have repaired the
coarctation and undertaken pulmonary artery banding
at the same time. A multi-institutional study demon-
strated that among patients with coexisting moderate-
to large-sized VSDs, repair of coarctation of the
aorta, pulmonary artery banding, and subsequent
repair of the VSD were associated with the highest 2-
year survival (ie, 97% in those with a single VSD).13
In our study the patients with concomitant VSDs did
not have a higher morbidity or mortality or reduced
